ZA924613B - Implant compositions containing a biologically active protein,peptide or polypeptide - Google Patents

Implant compositions containing a biologically active protein,peptide or polypeptide

Info

Publication number
ZA924613B
ZA924613B ZA924613A ZA924613A ZA924613B ZA 924613 B ZA924613 B ZA 924613B ZA 924613 A ZA924613 A ZA 924613A ZA 924613 A ZA924613 A ZA 924613A ZA 924613 B ZA924613 B ZA 924613B
Authority
ZA
South Africa
Prior art keywords
biologically active
peptide
polypeptide
active protein
compositions containing
Prior art date
Application number
ZA924613A
Other languages
English (en)
Inventor
William David Steber
David Steber William
Susan Mancini Cady
Mancini Cady Susan
David Farley Johnson
Farley Johnson David
Theresa Rice
Rice Theresa
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA924613B publication Critical patent/ZA924613B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/07—Stiffening bandages
    • A61L15/10—Stiffening bandages containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Prostheses (AREA)
ZA924613A 1991-06-24 1992-06-23 Implant compositions containing a biologically active protein,peptide or polypeptide ZA924613B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71989891A 1991-06-24 1991-06-24

Publications (1)

Publication Number Publication Date
ZA924613B true ZA924613B (en) 1993-03-31

Family

ID=24891827

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924613A ZA924613B (en) 1991-06-24 1992-06-23 Implant compositions containing a biologically active protein,peptide or polypeptide

Country Status (24)

Country Link
EP (1) EP0523330B1 (xx)
JP (1) JP3597205B2 (xx)
KR (1) KR100221031B1 (xx)
CN (1) CN1050301C (xx)
AT (1) ATE135565T1 (xx)
AU (1) AU656200B2 (xx)
BR (1) BR9202374A (xx)
CA (1) CA2071757C (xx)
DE (1) DE69209173T2 (xx)
DK (1) DK0523330T3 (xx)
ES (1) ES2087337T3 (xx)
GE (1) GEP19970992B (xx)
GR (1) GR3019457T3 (xx)
HU (1) HU217547B (xx)
IE (1) IE74398B1 (xx)
IL (1) IL102287A (xx)
LV (1) LV11816B (xx)
MD (1) MD1394G2 (xx)
MX (1) MX9203175A (xx)
RU (1) RU2080119C1 (xx)
SG (1) SG47955A1 (xx)
TW (1) TW215058B (xx)
UA (1) UA26137C2 (xx)
ZA (1) ZA924613B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
MXPA01000674A (es) * 1998-07-20 2002-04-08 Peptech Ltd Formulacion de bioimplante.
US8052982B2 (en) 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
JP2001058955A (ja) * 1999-06-17 2001-03-06 Inst Of Physical & Chemical Res 生理活性ペプチド徐放性製剤
AU2001238540A1 (en) 2000-02-24 2001-09-03 Monsanto Technology Llc Non-aqueous injectable formulations for extended release of somatotropin
WO2002000261A2 (en) 2000-06-26 2002-01-03 Monsanto Technology Llc Surfactant-containing formulations for extended release of somatotropin
US6664234B1 (en) 2000-06-30 2003-12-16 Monsanto Technology Llc Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
JP4931282B2 (ja) * 2000-10-02 2012-05-16 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
JP2005145821A (ja) * 2003-11-11 2005-06-09 Kao Corp 打錠製剤
CN102753573A (zh) 2009-12-21 2012-10-24 Ambrx公司 经过修饰的牛促生长素多肽和其用途
AU2010341518B2 (en) 2009-12-21 2014-01-09 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271113A (en) * 1978-04-17 1981-06-02 Alza Corporation Process for forming a passageway in an osmotic device
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
CA2088982A1 (en) * 1990-08-09 1992-02-10 Robert J. Leonard Multiple drug delivery system

Also Published As

Publication number Publication date
JPH05186363A (ja) 1993-07-27
CA2071757C (en) 2003-06-10
TW215058B (xx) 1993-10-21
LV11816A (lv) 1997-08-20
JP3597205B2 (ja) 2004-12-02
GEP19970992B (en) 1997-11-20
EP0523330B1 (en) 1996-03-20
MD1394G2 (ro) 2000-11-30
HUT61486A (en) 1993-01-28
IE922020A1 (en) 1992-12-30
EP0523330A1 (en) 1993-01-20
KR100221031B1 (ko) 1999-09-15
BR9202374A (pt) 1993-01-26
GR3019457T3 (en) 1996-06-30
UA26137C2 (uk) 1999-06-07
DE69209173D1 (de) 1996-04-25
KR930000131A (ko) 1993-01-15
CA2071757A1 (en) 1992-12-25
MX9203175A (es) 1993-04-01
MD1394F2 (en) 2000-01-31
HU9202092D0 (en) 1992-09-28
ES2087337T3 (es) 1996-07-16
DK0523330T3 (da) 1996-04-15
IL102287A0 (en) 1993-01-14
RU2080119C1 (ru) 1997-05-27
MD940370A (en) 1996-06-28
DE69209173T2 (de) 1996-11-28
AU656200B2 (en) 1995-01-27
LV11816B (en) 1997-12-20
ATE135565T1 (de) 1996-04-15
IE74398B1 (en) 1997-07-30
IL102287A (en) 2000-06-01
CN1068965A (zh) 1993-02-17
AU1847092A (en) 1993-01-07
SG47955A1 (en) 1998-04-17
CN1050301C (zh) 2000-03-15
HU217547B (hu) 2000-02-28

Similar Documents

Publication Publication Date Title
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
EP0212474A3 (en) Bone morphogenetic peptides
FI101938B1 (fi) Polypeptidijohdannaisia
ZA941771B (en) Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
GR3021708T3 (en) Human vascular permeability factor
GR3030382T3 (en) Cytokine restraining agents.
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
LV11816B (en) Implant compositions containing a biologically active protein, peptide or polypeptide
NZ216832A (en) Bovine growth hormone implant
EP0383837A4 (en) Alveolar surfactant proteins
GR3031927T3 (en) Cysteine depleted il-6 muteins
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DE69002881T2 (de) Peptide und deren Benutzung.
NZ220325A (en) Implants containing peptide or protein medicament in permeable polymeric coating
EP0723016A3 (en) Leukocyte activation factor
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.